Free Trial

Ardelyx (ARDX) Competitors

$5.89
+0.07 (+1.20%)
(As of 07/12/2024 ET)

ARDX vs. OPK, MIRM, ETNB, FLXN, XBIT, APLS, SWTX, ARVN, CPRX, and AMPH

Should you be buying Ardelyx stock or one of its competitors? The main competitors of Ardelyx include OPKO Health (OPK), Mirum Pharmaceuticals (MIRM), 89bio (ETNB), Flexion Therapeutics (FLXN), XBiotech (XBIT), Apellis Pharmaceuticals (APLS), SpringWorks Therapeutics (SWTX), Arvinas (ARVN), Catalyst Pharmaceuticals (CPRX), and Amphastar Pharmaceuticals (AMPH). These companies are all part of the "medical" sector.

Ardelyx vs.

Ardelyx (NASDAQ:ARDX) and OPKO Health (NASDAQ:OPK) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, media sentiment, community ranking, dividends, risk, institutional ownership and earnings.

OPKO Health has a net margin of -31.44% compared to Ardelyx's net margin of -41.36%. OPKO Health's return on equity of -17.89% beat Ardelyx's return on equity.

Company Net Margins Return on Equity Return on Assets
Ardelyx-41.36% -41.65% -23.08%
OPKO Health -31.44%-17.89%-12.26%

Ardelyx has higher earnings, but lower revenue than OPKO Health. Ardelyx is trading at a lower price-to-earnings ratio than OPKO Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ardelyx$124.46M11.01-$66.07M-$0.28-21.04
OPKO Health$863.50M1.11-$188.86M-$0.35-3.94

Ardelyx received 25 more outperform votes than OPKO Health when rated by MarketBeat users. Likewise, 67.40% of users gave Ardelyx an outperform vote while only 65.61% of users gave OPKO Health an outperform vote.

CompanyUnderperformOutperform
ArdelyxOutperform Votes
523
67.40%
Underperform Votes
253
32.60%
OPKO HealthOutperform Votes
498
65.61%
Underperform Votes
261
34.39%

In the previous week, Ardelyx had 4 more articles in the media than OPKO Health. MarketBeat recorded 9 mentions for Ardelyx and 5 mentions for OPKO Health. Ardelyx's average media sentiment score of 1.02 beat OPKO Health's score of 0.85 indicating that Ardelyx is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ardelyx
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
OPKO Health
2 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Ardelyx has a beta of 0.83, meaning that its stock price is 17% less volatile than the S&P 500. Comparatively, OPKO Health has a beta of 1.65, meaning that its stock price is 65% more volatile than the S&P 500.

58.9% of Ardelyx shares are owned by institutional investors. Comparatively, 64.6% of OPKO Health shares are owned by institutional investors. 5.5% of Ardelyx shares are owned by company insiders. Comparatively, 47.3% of OPKO Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Ardelyx currently has a consensus price target of $11.31, suggesting a potential upside of 92.06%. OPKO Health has a consensus price target of $3.17, suggesting a potential upside of 129.47%. Given OPKO Health's higher possible upside, analysts plainly believe OPKO Health is more favorable than Ardelyx.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ardelyx
0 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
3.00
OPKO Health
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Ardelyx and OPKO Health tied by winning 9 of the 18 factors compared between the two stocks.

Get Ardelyx News Delivered to You Automatically

Sign up to receive the latest news and ratings for ARDX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ARDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ARDX vs. The Competition

MetricArdelyxPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$1.37B$7.31B$5.40B$8.73B
Dividend YieldN/A2.73%2.77%4.03%
P/E Ratio-21.0411.88108.9715.72
Price / Sales11.01315.842,183.7683.88
Price / CashN/A33.2136.4333.15
Price / Book8.185.844.944.46
Net Income-$66.07M$146.83M$111.51M$215.59M
7 Day Performance11.34%10.49%6.20%5.35%
1 Month Performance-7.24%6.45%5.71%4.39%
1 Year Performance73.24%0.03%6.49%1.77%

Ardelyx Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OPK
OPKO Health
4.536 of 5 stars
4.54 / 5 stars
$1.38
+0.7%
$3.17
+129.5%
-34.0%$961.85M$863.50M-3.943,930Insider Selling
MIRM
Mirum Pharmaceuticals
4.6999 of 5 stars
4.70 / 5 stars
$39.44
+4.7%
$53.64
+36.0%
+51.5%$1.86B$186.37M-10.63278
ETNB
89bio
1.0456 of 5 stars
1.05 / 5 stars
$8.78
+0.1%
$26.67
+203.7%
-52.7%$863.81MN/A-4.3770News Coverage
Positive News
Gap Up
FLXN
Flexion Therapeutics
0 of 5 stars
0.00 / 5 stars
$9.12
flat
N/AN/A$458.93M$85.55M-4.54257Analyst Forecast
XBIT
XBiotech
0 of 5 stars
0.00 / 5 stars
$6.22
-6.6%
N/A+13.3%$189.45M$4.01M-6.1082Short Interest ↓
News Coverage
Positive News
APLS
Apellis Pharmaceuticals
4.2484 of 5 stars
4.25 / 5 stars
$39.53
+1.6%
$75.56
+91.2%
-54.0%$4.80B$396.59M-11.42770Short Interest ↑
News Coverage
SWTX
SpringWorks Therapeutics
1.2003 of 5 stars
1.20 / 5 stars
$41.44
+0.2%
$68.83
+66.1%
+46.1%$3.07B$5.45M-8.06230News Coverage
Gap Up
ARVN
Arvinas
1.1233 of 5 stars
1.12 / 5 stars
$28.87
+0.9%
$61.13
+111.8%
+17.2%$1.98B$78.50M-4.87420Short Interest ↑
News Coverage
CPRX
Catalyst Pharmaceuticals
4.9224 of 5 stars
4.92 / 5 stars
$16.58
+1.7%
$27.80
+67.7%
+31.4%$1.96B$398.20M30.7080Short Interest ↓
News Coverage
Positive News
AMPH
Amphastar Pharmaceuticals
4.9002 of 5 stars
4.90 / 5 stars
$38.70
-1.2%
$66.00
+70.5%
-30.0%$1.89B$676.21M13.391,620Positive News

Related Companies and Tools

This page (NASDAQ:ARDX) was last updated on 7/14/2024 by MarketBeat.com Staff

From Our Partners